Robert C. SEEGER,Muller FABBRI,Ambrose JONG,Alan S. WAYNE
申请号：
US15029395
公开号：
US20160243192A1
申请日:
2014.10.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Described herein are methods, pharmaceutical compositions and kits for treating cancer in a subject in need thereof by administering an effective amount of a composition comprising exosomes that comprise Fc receptors. In some embodiments, the exosomes in the pharmaceutical compositions described herein comprise Fc receptors including Fcgamma1 (CD64), Fcgamma2 (CD32), Fcgamma3 (CD16) or combinations thereof.
